Sunday, March 16, 2025

Week in Review 11/25

 



Welcome and thanks for reading!

In this review, I will make a summary of important and interesting news and events over the last week related to my portfolio holdings. Also, I will put together some interesting articles from other websites that caught my attention during the past week.



Received Dividends:



March 10, 2025


  • €70.48 – Chevron Corporation (CVX)
  • €73.80 – Pfizer Inc. (PFE)
  • €16.31 – Amgen Inc. (AMGN)
  • €21.61 – Emerson Electric Co. (EMR)
  • €48.29 – JPM Global Equity Premium Income Active UCITS ETF (JGPI.DE)
  • €4.76 – JPM US Equity Premium Income Active UCITS ETF USD Dist (JEIP.DE)
  • €7.25 – JPM Nasdaq Equity Premium Income Active UCITS ETF USD Dist (JEQP.DE)


March 11, 2025


  • €29.60 – Archer-Daniels-Midland Company (ADM)
  • €9.67 – Metro Inc. (TSE:MRU)


March 12, 2025


  • €25.63 – Global X SuperDividend™ ETF (SDIV)


March 14, 2025


  • €159.21 – Avance Gas Holding Ltd (AVANCE)
  • €16.79 – Avista Corporation (AVA)
  • €14.08 – The Hershey Company (HSY)
  • €78.17 – Prudential Financial, Inc. (PRU)


Week 11: Total net dividends €575.66


Dividend income is reported after the deduction of taxes. Check more at my Monthly Dividend sheet.



Portfolio Holdings News:



March 10, 2025



  • NCC AB (NCC) divests new public properties project in Espoo; NCC is divesting the public properties project Cleantech Garden in Espoo, Finland, comprising approximately 13,750 square meters of lettable area for SEK 900 million. The buyer is Suohki, a social infrastructure company in Finland, wholly owned by Infranode. The City of Espoo will be the largest tenant in the property with a new school.




March 11, 2025


  • Bristol-Myers Squibb Company (BMY) to acquire cell therapy partner 2seventy bio; 2seventy bio, Inc. (Nasdaq: TSVT), announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) will acquire all of the outstanding shares of 2seventy bio at a price of $5.00 per share in an all-cash transaction for a total equity value of approximately $286 million, or $102 million net of estimated cash.


  • Emerson Electric Co. (EMR) to Acquire Remaining Outstanding Shares of AspenTech; EMR and Aspen Technology, Inc. (NASDAQ: AZPN) announced that they have reached an agreement under which Emerson will acquire all outstanding shares of common stock of AspenTech not already owned by Emerson for $265.00 per share pursuant to an all-cash tender offer. The transaction values the minority stake being acquired at $7.2 billion, and values the total company at a fully diluted market capitalization of $17.0 billion with an enterprise value of $16.8 billion.


  • Eaton Corporation plc (ETN) signs agreement to acquire Fibrebond Corporation; ETN announced it has signed an agreement to acquire Fibrebond Corporation, a designer and builder of pre-integrated modular power enclosures for data center, industrial, utility and communications customers. Under the terms of the agreement, Eaton will pay $1.4 billion for the acquisition of Fibrebond, which is expected to generate $110 million of estimated 2025 adjusted EBITDA.


March 12, 2025



  • Realty Income Corporation (O) Declared Monthly Dividend Increase; O announced it has declared an increase in the company's common stock monthly cash dividend to $0.2685 per share, 0.2% increase from prior dividend of $0.2680 per share. The dividend is payable on April 15, 2025, to stockholders of record as of April 1, 2025.


March 13, 2025


  • Lockheed Martin Corporation (LMT) has been awarded a $1.93B U.S. Air Force contract action modification to a previously awarded contract for Joint Air to Surface Standoff Missile and Long-Range Anti-Ship Missile.


March 14, 2025



  • Lockheed Martin Corporation (LMT) has been awarded a $122.57M contract modification by the U.S. Air Force to a previously awarded contract to procure tooling and test equipment needed to increase production quantities of Joint Air-to-Surface Standoff Missile and Long-Range Anti-Ship Missile.



Articles that caught my attention:





Thanks for stopping by!


No comments:

Post a Comment